Status:
COMPLETED
Passive Disinfection Cap Compliance Study
Lead Sponsor:
Solventum US LLC
Collaborating Sponsors:
Eurotrials Brasil Consultores Cientificos Ltda
3M
Conditions:
Infection, Hospital
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Insertion and maintenance of central venous catheter (CVC) lines are common hospital procedures in patients, including those being treated for cancer. CVCs allow clinicians an access point for infusio...
Detailed Description
Insertion and maintenance of central venous catheter (CVC) lines are common hospital procedures in patients, including those being treated for cancer. CVCs allow clinicians an access point for infusio...
Eligibility Criteria
Inclusion
- Adult patients admitted to the participant oncologic hospital
- Adult patients in the assigned intervention units during the seven month intervention period who require needleless connectors for CVC IV tubing access.
Exclusion
- Adult patients admitted to the participant oncologic hospital during the seven month intervention period that do not require needleless connectors for CVC IV access during their hospital stay.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT03391960
Start Date
April 1 2018
End Date
October 31 2018
Last Update
October 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
3M HealthCare
Maplewood, Minnesota, United States, 55144